新闻Erytech partnered with Pherecydes Pharma, limited on Feb 15th '23.On February 15, 2023, Erytech announced its intended strategic combination with Pherecydes to create a global player in extended phage.
新闻Erytech is developing ERYCAPS platform.Leveraging its proprietary ERYCAPS® platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs.
新闻Erytech merged with Pherecydes Pharma, limited on Jan 1st '21.Pherecydes Pharma announced on February 15, 2023 its plan to merge with Erytech, which will be subject to the approval of the respective shareholders of both companies.
